Presentation shared by author at the 2017 EDEN Annual Conference "Diversity Matters!" held on 13-16 June 2017, in Jönköping, Sweden. Find out more on #eden17 here: http://www.eden-online.org/2017_jonkoping/
social pharmacy d-pharm 1st year by Pragati K. Mahajan
A Different Kind of Open: Patents and Public Knowledge - Eva Hemmungs Wirten #eden17
1.
2. L’ESPCI ParisTech est à la fois une Grande École d’ingénieurs
originale, un centre de recherche de renommée internationale et un
générateur fécond d’innovation pour l’industrie.
Fondée en 1882 sous l’égide de la Ville de Paris, l’École attire depuis plus
d’un siècle les plus grands esprits scientifiques novateurs : Pierre et
Marie Curie, Paul Langevin, Frédéric Joliot-Curie, Pierre-Gilles de Gennes et
Georges Charpak sont autant de noms illustres qui contribuent à la
réputation de l’ESPCI ParisTech, notamment à l’étranger.
Aujourd’hui, la culture d’excellence est plus que jamais vivante au cœur
même de l’École : 60% des élèves-ingénieurs préparent une thèse et
deviennent docteurs-ingénieurs ; les enseignants-chercheurs et
chercheurs de l’École construisent le savoir de demain et publient 1 article
par jour dans les meilleures revues scientifiques internationales ; ils
inventent l’industrie du futur et déposent 1 brevet par semaine.
Enfin, l’ESPCI ParisTech est la seule école d’ingénieurs lauréate tout à la
fois d’Équipements d’excellence (Équipex), de Laboratoires d’excellence
(Labex) et d’une Initiative d’excellence (Idex).
Modèle d’excellence et d’exception à la française, l’ESPCI ParisTech est
4. “The monopoly that the peer-reviewed journal exercised as the
rightful channel by which to circulate and to stake scientific
claims during the twentieth century is now giving way to a new
mixed economy of genres that include preprint archives, working
papers, and patent documents.”
Alex Csiszar (2010),“Seriality and the Search for Order:
Scientific Print and Its Problems During the Late Nineteenth Century,” History of Science (48:3-4), p. 428, note 14.
6. “any scientist who patented research put at risk his professional
integrity. Still, if a scientist wanted to protect his rights as a
discoverer, he would have to patent”
Paul Lucier (1996) “Court and Controversy: Patenting Science in the Nineteenth Century,”
The British Journal for the History of Science 2, 154.
8. with the following information for on-going grants and applications:
Project Title, Funding source, Amount, Period, Role of the PI, Relation to ERC project
c. Early achievements track-record28
(max. 2 pages):
The Principal Investigator (PI) must provide a list of achievements reflecting their track record.
The PI should list his/her activity as regards (if applicable):
1. Publications (up to five for Starting Grant and up to ten for Consolidator Grant) in major
international peer-reviewed multi-disciplinary scientific journals and/or in the leading
international peer-reviewed journals, peer-reviewed conferences proceedings and/or
monographs of their respective research fields, highlighting those without the presence as
co-author of their PhD supervisor, and the number of citations (excluding self-citations) they
have attracted;
2. Research monographs and any translations thereof;
3. Granted patent(s);
4. Invited presentations to peer-reviewed, internationally established conferences and/or
international advanced schools;
5. Prizes/Awards/Academy memberships.
Part B2 Sections a, b, and c:
The scientific proposal (max. 15 pages)
This part is evaluated only in step 2 of the peer review evaluation.
Please use the Word-template provided online in the Participant Portal Submission Page for the
call. References do not count towards the page limit.
The scientific, technical, and/or scholarly aspects of the project should be described more in detail
demonstrating the ground-breaking nature of the research, its potential impact and research
methodology. The fraction of the applicant's research effort that will be devoted to this project and a
full estimation of the real project costs also need to be indicated.
9. Patents as Scientific Information, 1895-2020
ERC 2016 Advanced Grant 741095 (2017-2022), 2.3 mil. euro
* Here and there, at random, anywhere, everywhere
PASSIM*
10.
11. In the eye of the storm stands the patent bargain: disclosure of
information in return for a limited monopoly. This contractual
moment makes patents a source of information, the basis of new
innovation.
Or does it?
12. “the study of patented information is
essential to the creation of new
knowledge, thereby achieving further
scientific and technological progress.”
(Judge Newman cited in Matthew Rimmer, Intellectual Property
and Biotechnology (2008, 176)
13. PASSIM’s objective is to unpack the multifaceted relationships
featured in the patent bargain, recombine them in unexpected
and creative ways and develop from that conceptualization a
new narrative of patents and intellectual property (ip). PASSIM
delivers an innovative new framework for understanding of
how information is disseminated and used (or not), within
contemporary knowledge infrastructures.
14.
15.
16.
17.
18. Media Contact
Home Searching for patents Applying for a patent Law & practice News & issues Learning & events About us
English
Home > Learning & events > Materials & programmes > Inventors' handbook > Novelty and prior art > What is prior art?
What is prior art?
Print Share
Prior art is any evidence that your invention is already known.
Prior art does not need to exist physically or be commercially available. It is enough that someone, somewhere, sometime
previously has described or shown or made something that contains a use of technology that is very similar to your invention.
A prehistoric cave painting can be prior art. A piece of technology that is centuries old can be prior art. A previously described
idea that cannot possibly work can be prior art. Anything can be prior art.
An existing product is the most obvious form of prior art. This can lead many inventors to make a common mistake: just
because they cannot find a product containing their invention for sale in any shops, they assume that their invention must be
novel.
The reality is very different. Many inventions never become products, yet there may be evidence of them somewhere.
That evidence - whatever form it may take - will be prior art.
19. Patents as Scientific Information, 1895-2020
[PASSIM*]
* “here and there, at random, anywhere, everywhere.”